The diagnosis that keeps surprising people
A woman gets diagnosed with polycystic ovary syndrome (PCOS) after years of irregular periods.
She's told to expect fertility challenges. Maybe acne. Maybe extra hair growth.
What she's often not told: her liver, heart, muscles, and pancreas may also be quietly under strain.
PCOS affects about 11 to 13 percent of women — roughly one in eight.
In women with obesity, that number climbs to around 28 percent.
For decades, it was viewed mainly as a reproductive problem. That framing missed most of what's actually happening inside the body.
This review pulls those hidden effects into the spotlight.
The old view versus the new view
The old view: PCOS is an ovary problem that causes irregular cycles and makes pregnancy harder.
The new view: PCOS is a systemic metabolic condition with reproductive symptoms on top.
Here's the twist. The same forces that mess with the ovaries also disrupt organs far away from them.
The "pathophysiological quartet"
The review highlights four forces that drive PCOS throughout the body:
- Insulin resistance — when cells stop responding well to insulin, the hormone that manages blood sugar.
- Hyperandrogenism — higher-than-typical levels of "male" hormones like testosterone.
- Chronic inflammation — a low, constant simmer of immune activity.
- Oxidative stress — cellular damage from unstable molecules called free radicals.
Think of these four as a group of instigators. Alone, each one causes trouble. Together, they feed each other and create a cycle that's hard to break.
How it shows up in the liver
One of the most common — and under-discussed — PCOS complications is MASLD (metabolic dysfunction–associated steatotic liver disease). That's the new name for what used to be called fatty liver.
Among women with PCOS and obesity, MASLD shows up in roughly 51.6 percent — more than half.
That's a silent threat. Fatty liver often has no early symptoms but can progress to scarring over years.
How it shows up in the heart
Women with PCOS have a 2 to 4 times higher risk of type 2 diabetes and cardiovascular disease compared to women without it.
That's not a small bump. That's a major shift in long-term risk.
The review argues these risks start earlier than most clinicians assume — often in a woman's 20s and 30s — and deserve earlier screening.
How it shows up in muscle and pancreas
Two less-discussed effects deserve attention.
Sarcopenia — the gradual loss of muscle mass and strength — can creep in even in younger women with PCOS. Muscle is where much of the body's blood sugar gets used, so losing muscle makes insulin resistance worse.
Beta-cell exhaustion happens when the pancreas spends years overproducing insulin to fight resistance, until the cells that make insulin start to wear out. That's the road to type 2 diabetes.
This isn't about blame. It's about biology.
Why fragmented care is the real problem
Picture a woman with PCOS. She sees a gynecologist for cycles, a dermatologist for skin, maybe an endocrinologist for blood sugar, and a primary care doctor for everything else.
Each one treats their slice.
Nobody sees the whole.
The authors argue this fragmented approach is no longer good enough. PCOS, they say, demands integrated, multidisciplinary care — a team that treats the patient as a full metabolic system.
This review isn't the first to make this case, but it's part of a growing shift.
Major guidelines have already moved toward broader screening for metabolic health, mental health, and cardiovascular risk in PCOS. The message here is that clinical practice still hasn't caught up.
If you have PCOS — or think you might — ask your care team about more than cycles.
Reasonable questions include:
- Have my liver enzymes been checked?
- What's my current insulin resistance or blood sugar picture?
- What's my cardiovascular risk profile?
- Am I getting enough strength-building activity to protect muscle?
Weight is often discussed in PCOS, sometimes unkindly. The more useful focus is on metabolic health — blood sugar control, muscle strength, sleep, and cardiovascular fitness. Those can improve even when weight doesn't change much.
Limitations to keep in mind
This is a review article. It summarizes existing studies rather than producing new data.
Some of the headline numbers — like the 51.6 percent liver disease rate — come from specific groups (like women with both PCOS and obesity) and won't match every patient.
Large prospective studies are still needed to track how organ-by-organ risks evolve over a lifetime.
The future of PCOS care likely looks team-based: gynecology, endocrinology, hepatology, cardiology, nutrition, and mental health working together.
For patients, that shift can't come soon enough.
Because PCOS was never really about the ovaries alone. It was about the whole person all along.
